Intensifying the Anticancer Potential of Cationic Peptide Derived from Serine Threonine Protein Kinase of Teleost by Tagging with Oligo Tryptophan
- 8 Downloads
Abstract
Serine threonine protein kinase plays an important role in the cell growth, cell cycle regulation and development which shows a significant role in signal transduction pathway. In this study, a cationic peptide IE13 was derived from serine threonine protein kinase of a teleost fish and it was modified as IW13 by replacing the C-terminal residue with tryptophan. The anticancer potential of IE13 and IW13 was tested against three different types of cell lines HeLa (Human Cervical carcinoma cells), A549 (Human lung cancer cells) and MCF 7 (Human breast cancer cells) at different concentrations (300, 100, 30 and 10 µM) in semi logarithmic range. The results showed that the peptide IW13 showed EC50 of 92 µM for MCF 7, 102 µM for A549 and 85 µM for HeLa whereas, IE13 showed less growth inhibition on the tested cell lines. The flow cytometry study was conducted to demonstrate the cell cycle inhibition by the cationic peptide IW13 against HeLa cell line. Cytotoxicity studies of the cationic peptide showed no cytotoxicity against normal cell line (RAW 264.7). Tailoring of these properties was likely to be a key in safe and successful transfer of this peptide from laboratory experiments into clinical practice for pharmaceutical formulations.
Keywords
Serine threonine protein kinase Cationic antimicrobial peptide Cytotoxicity Anticancer HeLa A549 MCF 7Abbreviations
- STPK
Serine threonine protein kinase
- HeLa
Human cervical carcinoma cells
- A549
Adenocarcinoma human alveolar basal epithelial cells
- MCF 7
Human breast cancer cells (Michigan Cancer Foundation 7)
- CAPs
Cationic antimicrobial peptides
- PS
Phosphatidyl serine
- Trp
Tryptophan
- Cs
Channa striatus
- RAW 264.7
Murine macrophage cell line
- DMEM
Dulbecco’s modified eagle’s medium
- FCS
Foetal calf serum
- GIBCO
GIBCO cell culture media and reagents
- OD
Optical density
- PBS
Phosphate buffered saline
Notes
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no conflict of interest.
Research Involving Human and Animal Participants
This article does not contain any studies with human participants or animals performed by any of the authors.
References
- Abirami A, Venkatesh K, Ganesh MR, Mukesh P, Arasu MV, Al-Dhabi NA, Arockiaraj J (2017) Bactericidal activity of fish galectin 4 derived membrane-binding peptide tagged with oligotryptophan. Dev Comp Immunol 71:37–48CrossRefGoogle Scholar
- Ardito F, Giuliani M, Perrone D, Troiano G, Lo Muzio L (2017) The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (review). Int J Mol Med 40(2):271–280CrossRefGoogle Scholar
- Baxter AA, Lay FT, Poon IKH, Kvansakul M, Hulett MD (2017) Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects. Cell Mol Life Sci 74(20):3809–3825CrossRefGoogle Scholar
- Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semi-automated colorimetric assay: assessment of chemo sensitivity testing. Cancer 47:936–942Google Scholar
- Chan DI, Prenner EJ, Vogel HJ (2006) Tryptophan and arginine-rich antimicrobial peptides: structures and mechanisms of action, BBA. Biomembranes 1758:1184–1202CrossRefGoogle Scholar
- Cohen P (2001) The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture. Eur J Biochem 268:5001–5010CrossRefGoogle Scholar
- Cutrona KJ, Kaufman BA, Figueroa DM, Elmore DE (2015) Role of arginine and lysine in the antimicrobial mechanism of histone-derived antimicrobial peptides. FEBS Lett 589(24):3915–3920CrossRefGoogle Scholar
- Dai Y, Cai X, Shi W, Bi X, Su X, Pan M, Li H, Lin H, Huang W, Qian H (2017) Pro-apoptotic cationic host defense peptides rich in lysine or arginine to reverse drug resistance by disrupting tumor cell membrane. Amino Acids 49(9):1601–1610CrossRefGoogle Scholar
- Deslouches B, Di YP (2017) Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications. Oncotarget 8(28):46635–46651CrossRefGoogle Scholar
- Dobrzynska J, Szachowicz-Petelska B, Sulkowski S, Figaszewski Z (2005) Changes in electric charge and phospholipids composition in human colorectal cancer cells. Mol Cell Biochem 276:113–119CrossRefGoogle Scholar
- Duong DT, Singh S, Bagheri M, Verma NK, Schmidtchen A, Malmsten M (2016) Pronounced peptide selectivity for melanoma through tryptophan end-tagging. Sci Rep 6:24952CrossRefGoogle Scholar
- Edelman AM, Blumenthal DK, Krebs EG (1987) Protein serine/threonine kinases. Annu Rev Biochem 56:567–613CrossRefGoogle Scholar
- Felício MR, Silva ON, Gonçalves S, Santos NC, Franco OL (2017) Peptides with dual antimicrobial and anticancer activities. Front Chem 5:5CrossRefGoogle Scholar
- Gaspar D, Veiga AS, Castanho MA (2013) From antimicrobial to anticancer peptides. Rev Front Microbiol 4:294Google Scholar
- Gatti L, Zunino F (2005) Overview of tumor cell chemoresistance mechanisms. Methods Mol Med 111:127–148Google Scholar
- Harsha HC, Pandey A (2010) Phosphoproteomics in cancer. Mol Oncol 4(6):482–495CrossRefGoogle Scholar
- Hoskin DW, Ramamoorthy A (2008) Studies on anticancer activities of antimicrobial peptides. Biochem Biophys Acta 1778:357–375CrossRefGoogle Scholar
- Hristova K, Wimley WC (2011) A look at arginine in membranes. J Membr Biol 239:49–56CrossRefGoogle Scholar
- Hu J, Chen C, Zhang S, Zhao X, Xu H, Zhao X, Xu H, Zhao X, Lu JR (2011) Designed antimicrobial and antitumor peptides with high selectivity. Biomacromolecules 12:3839–3843CrossRefGoogle Scholar
- Jamie SM, Hoskin DW (2006) Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment. Expert Opin Investig Drugs 15(8):933–946CrossRefGoogle Scholar
- Lijie X, Yanling W, Ji M, Jianhua Y, Fuchun Z (2016) The antibacterial peptide from Bombyx mori cecropin XJ induced growth arrest and apoptosis in human hepatocellular carcinoma cells. Oncol Lett 12:57–62CrossRefGoogle Scholar
- Ravichandran G, Kumaresan V, Bhatt P, Arasu MV, Al-Dhabi NA, Arockiaraj J (2017) A cumulative strategy to predict and characterize antimicrobial peptides (AMPs) from protein database. Int J Pept Res Ther 23(2):281–290CrossRefGoogle Scholar
- Rekdal Ø, Haug BE, Kalaaji M et al (2011) Relative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicity. J Biol Chem 287(1):233–244CrossRefGoogle Scholar
- Srisailam S, Kumar TK, Arunkumar AI, Leung KW, Yu C, Chen HM (2001) Crumpled structure of the custom hydrophobic lytic peptide cecropin B3. Eur J Biochem 268:4278–4284CrossRefGoogle Scholar
- Stromstedt AA, Pasupuleti M, Schmidtchen A, Malmsten M (2009) Oligotryptophan-tagged antimicrobial peptides and the role of the cationic sequence. Biochem Biophys Acta 1788:1916–1923CrossRefGoogle Scholar
- Ting CH, Huang HN, Huang TC, Wu CJ, Chen JY (2014) The mechanisms by which pardaxin, a natural cationic antimicrobial peptide, targets the endoplasmic reticulum and induces c-FOS. Biomaterials 5:3627–3640CrossRefGoogle Scholar
- Tinnakorn T, Surachai M, Nisachon J, Nualyai Y, Sakda D, Theeranan T, Jureerut D, Sompong K (2016) Cationic antimicrobial peptides derived from Crocodylus siamensis leukocyte extract, revealing anticancer activity and apoptotic induction on human cervical cancer cells. Protein J 35:202–211CrossRefGoogle Scholar
- Wang P, Hu L, Liu G et al (2011) Prediction of antimicrobial peptides based on sequence alignment and feature selection methods. PLoS ONE 6(4):e18476CrossRefGoogle Scholar
- Yifan H, Zhibin C, Yen-Hsing L, Wei-Hsuan H, Bao-Hong L (2015) In vitro and in vivo anticancer activity of pardaxin against proliferation and growth of oral squamous cell carcinoma. Mar Drugs 14:2CrossRefGoogle Scholar
- Zasloff M (1987) Magainins a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84:5449–5453CrossRefGoogle Scholar